GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $19,952,000 | +53.4% | 251,000 | -6.4% | 0.64% | +20.2% |
Q3 2019 | $13,008,000 | +5.2% | 268,100 | +14.1% | 0.53% | +19.4% |
Q2 2019 | $12,361,000 | +399.0% | 235,000 | +37.1% | 0.44% | +335.3% |
Q4 2016 | $2,477,000 | -37.3% | 171,428 | 0.0% | 0.10% | -44.6% |
Q3 2016 | $3,951,000 | -86.3% | 171,428 | -90.1% | 0.18% | -83.7% |
Q2 2016 | $28,764,000 | +51.9% | 1,733,828 | +45.2% | 1.13% | +40.2% |
Q1 2016 | $18,934,000 | -49.7% | 1,193,811 | +2.6% | 0.81% | -47.1% |
Q4 2015 | $37,626,000 | +0.2% | 1,163,811 | +30.7% | 1.52% | +5.0% |
Q3 2015 | $37,549,000 | – | 890,620 | – | 1.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |